Progestogen-releasing intrauterine systems for heavy menstrual bleeding

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 6, 2020, Pages

  Bofill Rodriguez, Magdalena ^a   Lethaby, Anne ^a   Jordan, Vanessa ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; HEMATIN; HEMOGLOBIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEFENAMIC ACID; MINESTRIN; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROGESTERONE; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; NORETHISTERONE;

ABDOMINAL PAIN; ACNE; ACTINOMYCOSIS; ADENOMYOSIS; AMENORRHEA; ANXIETY DISORDER; ARTICLE; BLADDER PERFORATION; BREAST TENDERNESS; CYSTOVAGINAL FISTULA; DEPRESSION; DISEASE SEVERITY; DRUG RELEASE; DRUG WITHDRAWAL; DYSMENORRHEA; EDEMA; ENDOMETRIOSIS; ENDOMETRITIS; ENDOMETRIUM ABLATION; EUROPEAN QUALITY OF LIFE 5 DIMENSIONS QUESTIONNAIRE; FEVER; FOLLOW UP; GENITAL ULCER; HAIR LOSS; HEADACHE; HEALTH CARE COST; HEMATOMA; HEMATOMETRA; HUMAN; HYPERTENSION; HYSTERECTOMY; ILEUS; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; LEG PAIN; LIBIDO DISORDER; LOW DRUG DOSE; LOWER ABDOMINAL PAIN; MASTALGIA; MENORRHAGIA; MENSTRUATION; MULTIPLE CYCLE TREATMENT; NAUSEA; PATIENT SATISFACTION; PELVIC PAIN; PERITONITIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; QUALITY OF LIFE; SAFETY; SHORT FORM 36; SIDE EFFECT; SPOTTING; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TREATMENT FAILURE; TREATMENT OUTCOME; URETER DISEASE; URINE RETENTION; VAGINITIS; ENDOMETRIUM; FEMALE; INTRAUTERINE CONTRACEPTIVE DEVICE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIFIBRINOLYTIC AGENTS; CONTRACEPTIVES, ORAL; ENDOMETRIUM; FEMALE; HUMANS; HYSTERECTOMY; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MEFENAMIC ACID; MENORRHAGIA; NORETHINDRONE; PROGESTERONE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 85086355020     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002126.pub4     Document Type: Article

References (115)

1. Ashraf M, Habib-Ur-Rehman, A, Shehzad, Z, AlSharari S, Murtaza G. Clinical efficacy of levonorgestrel and norethisterone for the treatment of chronic abnormal uterine bleeding. Journal of the Pakistan Medical Association 2017; 67(9):1331-8. x-wiley/crsRef/13760628 [28924270]
2. Ashraf M, Murtaza G. Levonorgestrel intrauterine system and norethisterone for the treatment of chronic abnormal uterine bleeding: A randomized clinical comparison in the patients of Bahawalpur, Pakistan. Value in Health 2016; 19(7):A577. x-wiley/crsRef/13760629 [613235950]
3. Barrington JW, Arunkalaivanan AS, Abdel-Fattah M. Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003; 108(1):72-4. x-wiley/crsRef/3289358
4. Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in treatment of dysfunctional uterine bleeding. Obstetrics and Gynecology Clinics of North America 1997; 90(2):257-63. x-wiley/crsRef/3289363
5. Silva-Filho AL, Pereira FAN, de Souza SS, Loures LF, Rocha APC, Valadares CN, et al. Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomised controlled trial. Contraception 2013; 87(4):409-15. x-wiley/crsRef/3289365
6. de Souza SS, Camargos AF, de Rezende CP, Pereira FAN, Araujo CAA, Filho ALS. A randomised prospective trial comparing the levonorgestrel-releasing intrauterine system with thermal balloon ablation for the treatment of heavy menstrual bleeding. Contraception 2010; 81(3):226-31. x-wiley/crsRef/3289366
7. Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M. A Canadian, multicentre study comparing efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. Journal d'Obstetrique et Gynecologie du Canada: JOGC [Journal of Obstetrics and Gynaecology Canada: JOGC] 2009; 31(4):340-7. x-wiley/crsRef/13760631
8. Ergun B, Bastu E, Kuru O, Sen S, Kilic Y, Dural O. Comparison of rollerball endometrial ablation and levonorgestrel releasing intrauterine system in the management of abnormal uterine bleeding. International Journal of Gynaecology and Obstetrics 2012; 119(S3):S672. x-wiley/crsRef/3289368
9. Ergun B, Kuru O, Sen S, Kilic Y, Bastu E. Rollerball endometrial ablation versus levonorgestrel releasing intrauterine system in the management of abnormal uterine bleeding. Ginecologia.ro 2012; 8(30):199-201. x-wiley/crsRef/3289369
10. Ghazizadeh S, Panahi Z, Ghanbari Z, Menshadi AT, Farahmandian T, Javadian P. Comparative efficacy of Novasure, the levonorgestrel-releasing intrauterine system and hysteroscopic endometrial resection in the treatment of menorrhagia: a randomised clinical trial. Journal of Gynecologic Surgery 2014; 30(4):215-8. x-wiley/crsRef/3289451
11. Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. New England Journal of Medicine 2013; 368(2):128-37. x-wiley/crsRef/13760632
12. Gupta JK, Daniels JP, Middleton LJ, Pattison HM, Prileszky G, Roberts TE, et cols. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: The ECLIPSE trial. Health technology Assessment 2015; 19(88):1-118. x-wiley/crsRef/13760633 [DOI: 10.3310/hta19880]
13. Kai J, Middleton L, Daniels J, Tryposkiadis K, Pattison H, Gupta J. Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding: long-term randomised pragmatic trial in primary care. British Journal of General Practice 2016; 66(653):e861-e870. x-wiley/crsRef/13760634 [DOI: 10.3399/bjgp16X687577]
14. Sanghera S, Roberts T, Barton P, Daniels J, Middleton L, Gennard L, et al. Cost effectiveness of levonorgestrel intrauterine system for menorrhagia. BJOG 2013; 120:390-1. x-wiley/crsRef/3289372
15. Sanghera S, Roberts TE, Barton P, Frew E, Daniels J, Middleton L, et al. Levonorgestrel-releasing intrauterine system vs usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trial. PLOS One 2014; 9(3):e91891. x-wiley/crsRef/3289373
16. Beelen P, Van Den Brink MJ, Geomini P, Dekker J, Herman M, Duijnhoven R, et al. RCT comparing the LNG-IUS versus endometrial ablation in women with heavy menstrual bleeding (MIRA). International Journal of Gynaecology and Obstetrics 2018; 143(3):318-9. x-wiley/crsRef/13760636 [10.1002/ijgo.12582]
17. Herman MC, van den Brink MJ, Geomini PM, van Meurs HS, Huirne JA, Eising HP, et al. Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial. BMC Women's Health 2013; 13:32. x-wiley/crsRef/13760637
18. Halmesmaki K, Hurskainen R, Teperi J, Grenman S, Kivela A, Kujansuu E, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial. British Journal of Obstetrics and Gynaecology 2007; 114(5):563-8. x-wiley/crsRef/3289375
19. Halmesmaki K, Hurskainen R, Tiitinen A, Teperi J, Grenman S, Kivela A, et al. A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia - effect on FSH levels and menopausal symptoms. Human Reproduction (Oxford, England) 2004; 19(2):378-82. x-wiley/crsRef/3289376
20. Halmesmaki KH, Hurskainen RA, Paavonen JA, Tuppurainen MT. Randomised controlled trial of the effect of hysterectomy or LNG-IUS use on bone mineral density: a five-year follow up. Therapy 2006; 3(4):509-15. x-wiley/crsRef/3289377
21. Heliovaara-Peippo S, Halmesmaki K, Hurskainen R, Teperi J, Grenman S, Kivela A, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica 2009; 88(12):1389-96. x-wiley/crsRef/3289378
22. Heliovaara-Peippo S, Halmesmaki K, Hurskainen R, Teperi J, Grenman S, Kivela A, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial. British Journal of Obstetrics and Gynaecology 2010; 117(5):602-9. x-wiley/crsRef/3289379
23. Heliovaara-Peippo S, Hurskainen R, Teperi J, Aalto A-M, Grenman S, Halmesmaki K, et al. Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10 year randomised controlled trial. Obstetrical & Gynecological Survey 2014; 69(4):204-5. x-wiley/crsRef/3289380
24. Heliovaara-Peippo S, Hurskainen R, Teperi J, Aalto A-M, Grenman S, Halmesmaki K, et al. Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomised controlled trial. American Journal of Obstetrics and Gynecology 2013; 209(6):535.e1-14. x-wiley/crsRef/3289381
25. Heliovaara-Peippo S, Oksjoki R, Halmesmaki K, Kaaja R, Teperi J, Grenman S, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on cardiovascular disease risk factors in menorrhagia patients: a 10-year follow-up of a randomised trial. Maturitas 2011; 69(4):354-8. x-wiley/crsRef/3289382
26. Hurskainen R, Teperi J, Aalto A-M, Grenman S, Kivela A, Kujansuu E, et al. Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome. Acta Obstetrica et Gynecologica Scandinavica 2004; 83(4):401-3. x-wiley/crsRef/3289383
27. Hurskainen R, Teperi J, Rissanen P, Aalto A-M, Grenman S, Kivela A, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia. JAMA 2004; 291(12):1456-63. x-wiley/crsRef/3289384
28. Hurskainen R, Teperi J, Rissanen P, Aalto A-M, Grenman S, Kivela A, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001; 357(9252):273-7. x-wiley/crsRef/3289385
29. Inki P, Hurskainen R, Palo P, Ekholm E, Grenman S, Kivela A, et al. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system versus hysterectomy. Ultrasound in Obstetrics & Gynecology 2002; 20(4):381-5. x-wiley/crsRef/3289386
30. Leminen H, Heliovaara-Peippo S, Halmesmaki K, Teperi J, Grenman S, Kivela A, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on premenstrual symptoms in women treated for menorrhagia: secondary analysis of a randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica 2012; 91(3):318-25. x-wiley/crsRef/3289387
31. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for the treatment of idiopathic menorrhagia. British Journal of Obstetrics and Gynaecology 1998; 105(6):592-8. x-wiley/crsRef/3289389
32. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, DeSanctis Y, Jensen J. Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels. Contraception 2012; 86(5):452-7. x-wiley/crsRef/3289391
33. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding. Obstetrics and Gynecology 2010; 116(3):625-32. x-wiley/crsRef/3289392
34. Kilic S, Yuksel B, Doganay M, Bardakci H, Akinsu F, Uzunlar O, et al. The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement. Contraception 2009; 80(2):152-7. x-wiley/crsRef/3289394
35. Kiseli M, Kayikcioglu F, Evliyaoglu O, Haberal A. Comparison of therapeutic efficacies of norethisterone, tranexamic acid and levonorgestrel-releasing intrauterine system for the treatment of heavy menstrual bleeding: a randomized controlled study. Gynecologic and Obstetric Investigation 2016; 81(5):447-53. x-wiley/crsRef/13760639 [CRSSTD: 7929734]
36. Istre O, Trolle B. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertility and Sterility 2001; 76(2):304-9. x-wiley/crsRef/3289396
37. Kittelsen N, Istre O. A randomized study comparing levonorgestrel intrauterine system (LNG IUS) and transcervical resection of the endometrium (TCRE) in the treatment of menorrhagia: preliminary results. Gynaecological Endoscopy 1998; 7(2):61-5. x-wiley/crsRef/3289397
38. Rauramo I, Elo I, Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstetrics and Gynecology 2004; 104(6):1314-21. x-wiley/crsRef/3289398
39. Malak KA, Shawki O. Management of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Gynecological Surgery 2006; 3(4):275-80. x-wiley/crsRef/3289400
40. Ozdegirmenci O, Kayikcioglu F, Akgul MA, Kaplan M, Karcaaltincaba M, Haberal A, et al. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertility and Sterility 2011; 95(2):497-502. x-wiley/crsRef/3289402
41. Reid PC, Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss measurements. British Journal of Obstetrics and Gynaecology 2005; 112(8):1121-5. x-wiley/crsRef/13760641
42. Sayed GH, Zakherah MS, El-Nashar SA, Shaaban MM. A randomised clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia. International Journal of Gynaecology and Obstetrics 2011; 112(2):126-30. x-wiley/crsRef/3289406
43. Sesti F, Piancatelli R, Pietropoli A, Ruggeri V, Piccione E. Levonorgestrel-releasing intrauterine system versus laparoscopic supracervical hysterectomy for the treatment of heavy menstrual bleeding: a randomised study. Journal of Women's Health 2012; 21(8):851-7. x-wiley/crsRef/3289408
44. Shabaan MM, Zakherah MS, El-Nashar SA, Sayed GH. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomised clinical trial. Contraception 2011; 83(1):48-54. x-wiley/crsRef/3289410
45. Shaw RW, Symonds IM, Tamizian O, Chaplain J, Mukhopadhyay S. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. Australian & New Zealand Journal of Obstetrics & Gynaecology 2007; 47(4):335-40. x-wiley/crsRef/3289412
46. Shaw RW, Symonds IM, Tamizian O. Randomised comparative trial of thermal balloon ablation (TBA) v levonorgestrel intrauterine system (LNG IUS) in idiopathic menorrhagia. In: XVIII FIGO World Congress of Gynecology and Obstetrics. Vol. 4. 2006:119. x-wiley/crsRef/3289413
47. Soysal M, Soysal S, Ozer S. A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia. Zentralblatt fur Gynakologie 2002; 124(4):213-9. x-wiley/crsRef/3289415
48. Brown PM, Farquhar CM, Lethaby A, Sadler LC, Johnson NP. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 2006; 113(7):797-803. x-wiley/crsRef/3289417
49. Busfield RA, Farquhar CM, Sowter MC, Lethaby A, Sprecher M, Yu Y, et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 2006; 113(3):257-63. x-wiley/crsRef/3289418
50. Tam WH, Yuen PM, Ng DPS, Leung PL, Lok IH, Rogers MS. Health status function after treatment with thermal balloon ablation and levonorgestrel intrauterine system for idiopathic menorrhagia: a randomised study. Gynecologic and Obstetric Investigation 2006; 62(2):84-8. x-wiley/crsRef/3289420
51. Abu Hashim H, Zayed A, Ghayaty E, El Rakhawy M. LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomised controlled trial. Journal of Gynecologic Oncology 2013; 24(2):128-34. x-wiley/crsRef/3289422
52. Adiguzel C, Seyfettinoglu S, Aka Satar D, Arlier S, Eskimez E, Kaya F, Nazik H. Evaluation of quality of life and cost-effectiveness of definitive surgery and the levonorgestrel intrauterine system as treatment options for heavy menstrual bleeding. Turkish Journal of Medical Sciences 2017; 47(3):789-94. x-wiley/crsRef/13760643 [DOI: 10.3906/sag-1512-115]
53. Apter D, Briggs P, Tuppurainen M, Grunert J, Lukkari-Lax E, Rybowski S, Gemzell-Danielsson K. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant. Fertility and Sterility 2016; 106(1):151-7.e5. x-wiley/crsRef/13760645 [DOI: 10.1016/j.fertnstert.2016.02.036]
54. Buyuktuna N, Sumer F. Comparison of mirena intrauterine device with oral progesterone treatment and surgical treatment in idiopathic menorrhagia patients: Results of a cost-minimisation analysis. Value in Health 2016; 19(7):A698. x-wiley/crsRef/13760647 [613234471]
55. Cameron IT, Leask R, Kelly RW, Baird DT. The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins 1987; 34(1):99-110. x-wiley/crsRef/3289360
56. Cameron IT. Dysfunctional uterine bleeding. Bailliere's Clinical Obstetrics and Gynaecology 1989; 3(2):315-27. x-wiley/crsRef/3289361
57. Ghazizadeh S, Bakhtiari F, Rahmanpour H, Davari-Tanha F, Ramezanzadeh F. A randomised clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs transcervical endometrial resection for treatment of menorrhagia. International Journal of Women's Health 2011; 3:207-11. x-wiley/crsRef/3289426
58. Gupta B, Mittal S, Misra R, Deka D, Dadhwal V. Levonorgestrel-releasing intrauterine system vs transcervical endometrial resection for dysfunctional uterine bleeding. International Journal of Gynaecology and Obstetrics 2006; 95:261-6. x-wiley/crsRef/3289428
59. Janssen CAH. Menorrhagia and the 3-keto-desogestrel-copper medicated intrauterine device. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1999; 85:135-6. x-wiley/crsRef/3289430
60. Karacaoglu U, Cebi Z, Savan K, Yasar L, Cankaya A, Kupelioglu L, et al. Comparing hysteroscopic ablation with levonorgestrel-releasing intrauterine device in abnormal uterine bleeding cases. Jinekoloji Ve Obstetrik Dergisi 2001; 15(3):172-5. x-wiley/crsRef/3289432
61. Karimi-Zarchi M, Dehghani-Firoozabadi R, Tabatabaie A, Dehghani-Firoozabadi Z, Teimoori S, Chiti Z, et al. A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation. Clinical and Experimental Obstetrics & Gynecology 2013; 40(3):421-4. x-wiley/crsRef/3289434
62. Kucuk U, Ertan K. Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomised prospective controlled trial in female smokers. Clinical and Experimental Obstetrics & Gynecology 2008; 35(1):57-60. x-wiley/crsRef/3289436
63. Lahteenmaki P, Haukkamaa M, Puolakka J, Riikonen U, Sainio S, Suvisaari J, et al. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 1998; 316:1122-6. x-wiley/crsRef/3289438
64. Lee BS, Ling X, Asif S, Kraemer P, Hanisch JU, Inki P. Levonorgestrel-releasing intrauterine system versus conventional medical therapy for heavy menstrual bleeding in the Asia-Pacific region. International Journal of Gynaecology and Obstetrics 2013; 121:24-30. x-wiley/crsRef/3289440
65. Xu L, Lee BS, Asif S, Kraemer P, Inki P. Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. International Journal of Women's Health 2014; 6:547-54. x-wiley/crsRef/3289441
66. Mawet M, Nollevaux F, Nizet D, Wijzen F, Gordenne V, Tasev N, et al. Impact of a new levonorgestrel intrauterine system, Levosert(), on heavy menstrual bleeding: results of a one-year randomised controlled trial. European Journal of Contraception & Reproductive Health Care 2014; 19(3):169-79. x-wiley/crsRef/13760649 [10.3109/13625187.2014.894184]
67. McMillan L. Randomised controlled study comparing the efficacy of Levonorgestrel intrauterine device with Nd:YAG laser endometrial ablation for the treatment of menorrhagia and premenstrual syndrome. National Research Register, id N0080056736. x-wiley/crsRef/3289453
68. McMillan L. Randomised controlled study comparing the efficacy of levonorgestrel intrauterine device with surgical treatment of menorrhagia by total endometrial ablation. National Research Register, id N0080056730. x-wiley/crsRef/3289455
69. Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology 1991; 164(3):879-83. x-wiley/crsRef/3289443
70. Rogerson L, Crocombe W, Duffy S. SMART - Satisfaction with Mirena and ablation: a randomised trial (abstract). In: British Society of Gynaecological Endocrinology. 1999. x-wiley/crsRef/3289445
71. Romer T. Prospective comparison study of levonorgestrel IUD versus Roller-Ball endometrial ablation in the management of refractory recurrent hypermenorrhea. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2000; 90(1):27-9. x-wiley/crsRef/3289447
72. Tosun AK, Tosun I, Suer N. Comparison of levonorgestrel-releasing intrauterine device with oral progestins in heavy menstrual bleeding (HMB) cases with uterine leiomyoma (LNG-IUD and oral progestin usage in myoma uteri). Pakistan Journal of Medical Sciences Quarterly 2014; 30(4):834-9. x-wiley/crsRef/3289449
73. SHiPP (Stopping Heavy Periods Project), Identifier NCT02002260. Ongoing study. February 2013 ‒ estimated completion date January 2017. Contact author for more information.
74. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994; 49(1):56-72.
75. Baldwin MK, Jensen JT. Contraception during the perimenopause. Maturitas 2013; 76(3):235-42.
76. Bayer SA. Number of countries around the world where Mirena is available. email to: Magdalena Bofill 2019.
77. Berqvist A, Rybo G. Treatment of menorrhagia with intrauterine release of progesterone. British Journal of Obstetrics and Gynaecology 1983; 90(3):255-8.
78. Chimbira TH, Anderson ABM, Turnbull AC. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. British Journal of Obstetrics and Gynaecology 1980; 87(7):603-9.
79. Clegg JP, Guest JF, Hurskainen R. Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK. Current Medical Research and Opinions 2007; 23(7):1637-48.
80. Cole SK, Billewicz WZ, Thomson AM. Sources of variation in menstrual blood loss. Journal of Obstetrics and Gynaecology of the British Commonwealth 1971; 78(10):933-9.
81. Cooper K, Lee AJ, Chien P, Raja EA, Timmaraju V, Bhattacharya S. Outcomes following hysterectomy or endometrial ablation for heavy menstrual bleeding: retrospective analysis of hospital episode statistics in Scotland. British Journal of Obstetrics and Gynaecology 2011; 118(10):1171-9. [DOI: 10.1111/j.1471-0528.2011.03011.x]
82. Farquhar C, Steiner C. Hysterectomy rates in the United States 1990-1997. Obstetrics and Gynecology 2002; 99(2):229-34.
83. Fergusson RJ, Lethaby A, Shepperd S, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD000329.pub2]
84. Fraser IS, Langham S, Uhl-Hochgraeber K. Health-related quality of life and economic burden of abnormal uterine bleeding. Expert Review of Obstetrics and Gynecology 2009; 4(2):179-89.
85. Ganz ML, Shah D, Gidwani R, Filonenko A, Su W, Pocoski J, et al. The cost effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States. Value in Health 2013; 16(2):325-33.
86. Goldstuck N. Clarification of the role of the Jaydess(Skyla) LNG- IUS 13.5mg and Kyleena LNG-IUS 19.5mg as intrauterine contraceptive systems. Expert Review of Medical Devices 2017; 14(8):593-9. [DOI: 10.1080/17434440.2017.1350169]
87. McMaster University (developed by Evidence Prime) GRADEpro Guideline Development Tool. GRADEpro, Version accessed 4 July 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org. [gradepro.org.]
88. Hallberg L, Hogahl AM, Nilsson L, Rybo G. Menstrual blood loss - a population study. Acta Obstetricia et Gynecologica Scandinavica 1966; 45(3):320-51.
89. Heikinheimo O, Fraser I. The current status of hormonal therapies for heavy menstrual bleeding. Best Practice & Research. Clinical Obstetrics & Gynaecology 2017; 40:111-20. [DOI: 10.1016/j.bpobgyn.2017.01.001]
90. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011] edition. The Cochrane Collaboration, 2011.
91. Higham JM, O'Brien PMS, Shaw RW. Assessment of menstrual blood using a pictorial chart. British Journal of Obstetrics and Gynaecology 1990; 97(8):734-9.
92. Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos L. Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis. Obstetrics and Gynecology 2009; 113(5):1104-16.
93. Kaunitz AM, Inki P. The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding. Drugs 2012; 72(2):193-215.
94. Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilisation in abnormal uterine bleeding. Value Health 2007; 10(3):183-94.
95. Matteson KA, Rahn DD, Wheeler TL, Casiano E, Siddiqui NY, Harvie HS, et al. Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstetrics and Gynecology 2013; 121(3):632-43.
96. McNicholas C, Maddipati R, Zhao Q, Swor E, Peipert J. Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration–approved duration. Obstetrics and Gynecology 2015; 125(3):599-604. [DOI: 10.1097/AOG.0000000000000690]
97. Middleton LJ, Champaneria R, Daniels JP, Bhattacharya S, Cooper KG, Hilken NH, et al. Hysterectomy, endometrial destruction and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ 2010; 341:c3929.
98. Moragianni VA, Somkuti SG. Profound hypothyroidism-induced acute menorrhagia resulting in life-threatening anemia. Obstetrics and Gynecology 2007; 110(2 Pt 2):515-7.
99. Munro MG, Critchley HO, Fraser IS. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? American Journal of Obstetrics and Gynecology 2012; 207(4):259-65. [DOI: 10.1016/j.ajog.2012.01.046]
100. National Institute for Health and Clinical Excellence. Heavy menstrual bleeding. pubmed.ncbi.nlm.nih.gov/21938862.
101. Nilsson CG, Luukkainen T, Arko H. Endometrial morphology of women using a d-norgestrel-releasing intrauterine device. Fertility and Sterility 1978; 29(4):397-401.
102. Reid PC, Mukri F. Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics 1989 to 2002-3. BMJ 2005; 330(7497):938-9.
103. Roberts TE, Tsourapas A, Middleton LJ, Champaneria R, Daniels JP, Cooper KG, et al. Hysterectomy, endometrial ablation and levonorgestrel releasing intrauterine system (Mirean) for treatment of heavy menstrual bleeding: cost effectiveness analysis. BMJ 2011; 342:d2202.
104. Rowe P, Farley T, Peregoudov A, Piaggio G, Boccard S, Landoulsi S, et al. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A. Contraception 2016; 93(6):498-506. [DOI: 10.1016/j.contraception.2016.02.024]
105. Sergison J, Maldonado L, Gao X, Hubacher D. Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology 2019; 220(5):440-8. [DOI: 10.1016/j.ajog.2018.12.008]
106. Shapley M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. British Journal of General Practice 2004; 54(502):359-64.
107. Somboonporn W, Panna S, Temtanakitpaisan T, Kaewrudee S, Soontrapa S. Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis. Menopause 2011; 18(10):1060-6.
108. Suvisaari J, Lahteenmaki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception 1996; 54(4):201-8.
109. Wright JD, Herzog TJ, Tsui J, Ananth CV, Lewin SM, Lu Y-S, et al. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstetrics and Gynecology 2013; 122(2):233-41.
110. Xu L, Lee BS, Asif S, Kraemer P, Inki P. Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. International Journal of Women's Health 2014; 6:547-54.
111. You JH, Sahota DS, MoYuen P. A cost utility analysis of hysterectomy, endometriation resection and ablation and medical therapy for menorrhagia. Human Reproduction 2006; 21(7):1878-83.
112. Zigler RE, McNicholas C. Unscheduled vaginal bleeding with progestin-only contraceptive use. American Journal of Obstetrics and Gynecology 2017; 216(5):443-50. [DOI: 10.1016/j.ajog.2016.12.008]
113. Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD002126]
114. Lethaby A, Cooke I, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD002126.pub2]
115. Lethaby A, Hussain M, Rishworth J, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2015, Issue 4. [DOI: 10.1002/14651858.CD002126.pub3]